How do you pay?

How to pay the least

Ask for the cash price

Voydeya

We didn’t find one.

  1. Ask your pharmacy for Voydeya’s cash price, and one or two other pharmacies too.
  2. Voydeya’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameVoydeya
Authorized genericdanicopan
Regular genericdanicopan
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Voydeya?
The original
–
–

Brand nameThe maker’s card

Alexion OneSource CoPay Program

Savings card from Alexion (AstraZeneca Rare Disease)

No insuranceNeeds insuranceNo cash price listed.
Insurance $0

Sign up on alexiononesource.com 

See the offer on alexiononesource.com

From the maker’s offer on alexiononesource.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Brand nameWith a free discount coupon

Optum Perks, Optum’s free discount coupon, lists these prices for Voydeya without insurance. Show the coupon from its page at the pharmacy; it can’t be used with insurance.

From Optum Perks, read November 2, 2026, with no location set. Its page opens on this dose; other doses and pharmacies near you are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized genericNot sold

There isn’t one. An authorized generic is Voydeya itself, from the same company, sold without the brand name, and usually for less. For now Voydeya is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VOYDEYA is a complement factor D inhibitor indicated as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH).

Limitations of Use

VOYDEYA has not been shown to be effective as monotherapy and should only be prescribed as an add-on to ravulizumab or eculizumab.

Source: the FDA label for Voydeya (Alexion Pharmaceuticals Inc.), May 12, 2026. Full label on DailyMed 

Good to know